Average Co-Inventor Count = 7.48
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (14 from 4,179 patents)
2. Abbvie Inc. (10 from 822 patents)
3. Leland Stanford Junior University (2 from 5,309 patents)
4. Walter and Eliza Hall Institute of Medical Research (1 from 83 patents)
5. Abbvie Bahamas Limited (6 patents)
26 patents:
1. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
3. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
4. 9072748 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
5. 8952157 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
6. 8853209 - 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
7. 8686136 - Apoptosis promoters
8. 8614318 - Apoptosis promoters
9. 8586754 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10. 8563735 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11. 8354404 - Apoptosis promoters
12. 8343967 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
13. 8338466 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
14. 8188077 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
15. 8173811 - Apoptosis promoters